CTLA-4 modulator antibody (University of Aberdeen/MRCT)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug NameCTLA-4 modulator antibody (University of Aberdeen/MRCT)
Drug Alias NameCTLA-4 modulator antibody (University of Aberdeen/Medical Research Council Technology)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionCytotoxic T-Lymphocyte-Associated Antigen 4 modulators
TargetsCytotoxic T-Lymphocyte-Associated Antigen 4
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Aberdeen
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLifearcUniversity Of Aberdeen
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A